HOPE Therapeutics Partners with Smith & Sauer for $27 Million in Strategic Funding HOPE Therapeutics and NRx Pharmaceuticals are poised for growth with a $27 million infusion aimed at mental health clinic expansions and innovative drug developments.

HOPE Therapeutics Partners with Smith & Sauer for $27 Million in Strategic Funding #USA #Miami #NRx_Pharmaceuticals #Hope_Therapeutics #Smith_Sauer